{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:39:28Z","timestamp":1768282768856,"version":"3.49.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Familial hypercholesterolaemia is a common genetic disorder that accelerates premature coronary heart disease. Although effective treatments are available, the majority of individuals remain undiagnosed. We review new evidence for improving the detection of familial hypercholesterolaemia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Recent studies have demonstrated that universal screening of children for familial hypercholesterolaemia may be highly effective at the time of immunization if combined with reverse cascade testing of adult family members, who have a more immediate risk of a coronary event. Alerts on laboratory reports and the application of bioinformatics to electronic health records may also be useful for identifying familial hypercholesterolaemia in community settings. Effective detection, diagnosis, and codification of familial hypercholesterolaemia are essential for the development of registries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Although the cost-effectiveness of screening programs for familial hypercholesterolaemia in childhood remains to be established, combining universal and reverse cascade screening, complemented by opportunistic identification of individuals in high-risk settings, use of laboratory alerts, and screening of electronic health records are likely to have a high yield in the detection of familial hypercholesterolaemia in the community.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000423","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T13:34:30Z","timestamp":1492608870000},"page":"321-327","source":"Crossref","is-referenced-by-count":16,"title":["Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies"],"prefix":"10.1097","volume":"28","author":[{"given":"Andrew C.","family":"Martin","sequence":"first","affiliation":[{"name":"Department of General Paediatrics, Princess Margaret Hospital for Children"},{"name":"School of Paediatrics and Child Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damon A.","family":"Bell","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, School of Medicine, University of Western Australia"},{"name":"Lipid Disorders Clinic, Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital, Perth"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Brett","sequence":"additional","affiliation":[{"name":"General Practice and Primary Care Research, School of Medicine, The University of Notre Dame Australia, Fremantle, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald F.","family":"Watts","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, School of Medicine, University of Western Australia"},{"name":"Lipid Disorders Clinic, Cardiometabolic Service, Department of Cardiology, Royal Perth Hospital, Perth"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230917","doi-asserted-by":"crossref","first-page":"3478a","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"R2-20230917","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jpeds.2015.11.019","article-title":"Prevalence of familial hypercholesterolemia in adolescents: potential value of universal screening?","volume":"170","author":"Pang","year":"2016","journal-title":"J Pediatr"},{"key":"R3-20230917","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S0140-6736(69)90930-1","article-title":"Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states","volume":"2","author":"Slack","year":"1969","journal-title":"Lancet"},{"key":"R4-20230917","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation"},{"key":"R5-20230917","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"R7-20230917","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","article-title":"Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"},{"key":"R8-20230917","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J"},{"key":"R9-20230917","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"R10-20230917","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"R11-20230917","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacl.2014.01.002","article-title":"Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation","volume":"8","author":"Watts","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R12-20230917","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R13-20230917","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: a model of care for Australasia","volume":"12","author":"Watts","year":"2011","journal-title":"Atheroscler Suppl"},{"key":"R14-20230917","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1586\/14779072.2015.1082907","article-title":"Challenges in the care of familial hypercholesterolemia: a community care perspective","volume":"13","author":"Brett","year":"2015","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"R15-20230917","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cca.2015.06.004","article-title":"The potential role of an expert computer system to augment the opportunistic detection of individuals with familial hypercholesterolaemia from a community laboratory","volume":"448","author":"Bell","year":"2015","journal-title":"Clin Chim Acta"},{"key":"R16-20230917","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2015-308824","article-title":"A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice","volume":"102","author":"Troeung","year":"2016","journal-title":"Heart"},{"key":"R17-20230917","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2014.12.034","article-title":"Improving identification of familial hypercholesterolaemia in primary care: derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)","volume":"238","author":"Weng","year":"2015","journal-title":"Atherosclerosis"},{"key":"R18-20230917","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.atherosclerosis.2015.04.809","article-title":"Prevalence and management of familial hypercholesterolaemia in coronary patients: an analysis of EUROASPIRE IV, a study of the European Society of Cardiology","volume":"241","author":"De Backer","year":"2015","journal-title":"Atherosclerosis"},{"key":"R19-20230917","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/eurheartj\/ehv602","article-title":"Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death","volume":"37","author":"Krogh","year":"2016","journal-title":"Eur Heart J"},{"key":"R20-20230917","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jacl.2016.08.013","article-title":"Identification of familial hypercholesterolemia in patients with myocardial infarction: a Chinese cohort study","volume":"10","author":"Li","year":"2016","journal-title":"J Clin Lipidol"},{"key":"R21-20230917","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.116.023007","article-title":"Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes","volume":"134","author":"Nanchen","year":"2016","journal-title":"Circulation"},{"key":"R22-20230917","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2016.03.023","article-title":"Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins","volume":"249","author":"Rallidis","year":"2016","journal-title":"Atherosclerosis"},{"key":"R23-20230917","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2016.08.001","article-title":"The prevalence and prognostic importance of possible familial hypercholesterolemia in patients with myocardial infarction","volume":"181","author":"Rerup","year":"2016","journal-title":"Am Heart J"},{"key":"R24-20230917","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.jacl.2016.08.010","article-title":"Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization","volume":"10","author":"Zafrir","year":"2016","journal-title":"J Clin Lipidol"},{"key":"R26-20230917","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R27-20230917","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2004-822992","article-title":"Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands","volume":"4","author":"Wonderling","year":"2004","journal-title":"Semin Vasc Med"},{"key":"R28-20230917","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajmg.a.34368","article-title":"The evaluation of cascade testing for familial hypercholesterolemia","volume":"158A","author":"Morris","year":"2012","journal-title":"Am J Med Genet A"},{"key":"R29-20230917","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.39300.616076.55","article-title":"Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis","volume":"335","author":"Wald","year":"2007","journal-title":"BMJ"},{"key":"R30-20230917","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jpeds.2011.06.006","article-title":"Child-parent screening for familial hypercholesterolemia","volume":"159","author":"Wald","year":"2011","journal-title":"J Pediatr"},{"key":"R31-20230917","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N Engl J Med"},{"key":"R32-20230917","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/10408363.2013.847896","article-title":"Inborn errors of metabolism and expanded newborn screening: review and update","volume":"50","author":"Mak","year":"2013","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R33-20230917","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1203\/00006450-198805000-00013","article-title":"Screening for familial hypercholesterolemia in 5000 neonates: a recall study","volume":"23","author":"Blades","year":"1988","journal-title":"Pediatr Res"},{"key":"R34-20230917","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2015.07.017","article-title":"Universal screening for familial hypercholesterolemia in children","volume":"66","author":"Klancar","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R35-20230917","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2015.06.1340","article-title":"Lipid screening in children","volume":"66","author":"Daniels","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R36-20230917","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1542\/peds.2009-2107C","article-title":"Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report","volume":"128","year":"2011","journal-title":"Pediatrics"},{"key":"R37-20230917","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jpeds.2013.10.027","article-title":"Implementation of lipid screening guidelines in children by primary pediatric providers","volume":"164","author":"Dixon","year":"2014","journal-title":"J Pediatr"},{"key":"R38-20230917","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jpeds.2016.08.016","article-title":"Referral patterns and cascade screening for familial hypercholesterolemia in a pediatric lipid clinic","volume":"178","author":"Stempel","year":"2016","journal-title":"J Pediatr"},{"key":"R39-20230917","doi-asserted-by":"crossref","first-page":"E263","DOI":"10.1111\/jpc.12036","article-title":"Familial hypercholesterolaemia in children and adolescents: a new paediatric model of care","volume":"49","author":"Martin","year":"2013","journal-title":"J Paediatr Child Health"},{"issue":"(3 Suppl)","key":"R40-20230917","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jacl.2011.03.453","article-title":"Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Daniels","year":"2011","journal-title":"J Clin Lipidol"},{"key":"R41-20230917","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.lpm.2013.01.053","article-title":"[Diagnostic and treatment of familial hypercholesterolemia (FH) in adult: guidelines from the New French Society of Atherosclerosis (NSFA)]","volume":"42","author":"Farnier","year":"2013","journal-title":"Presse Med"},{"key":"R42-20230917","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cjca.2014.09.028","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia","volume":"30","author":"Genest","year":"2014","journal-title":"Can J Cardiol"},{"key":"R43-20230917","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2011.03.001","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"J Clin Lipidol"},{"issue":"(2 Suppl 2)","key":"R44-20230917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5935\/abc.20120202","article-title":"[First Brazilian Guidelines for Familial Hypercholesterolemia]","volume":"99","author":"Santos","year":"2012","journal-title":"Arq Bras Cardiol"},{"key":"R45-20230917","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.5551\/jat.14621","article-title":"Guidelines for the management of familial hypercholesterolemia","volume":"19","author":"Harada-Shiba","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"R46-20230917","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/2047487314533218","article-title":"Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation","volume":"22","author":"Watts","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"R47-20230917","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacl.2016.07.011","article-title":"US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry","volume":"10","author":"Ahmad","year":"2016","journal-title":"J Clin Lipidol"},{"key":"R48-20230917","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2015.08.033","article-title":"Clinical features of familial hypercholesterolemia in Korea: Predictors of pathogenic mutations and coronary artery disease: a study supported by the Korean Society of Lipidology and Atherosclerosis","volume":"243","author":"Shin","year":"2015","journal-title":"Atherosclerosis"},{"key":"R49-20230917","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.amjcard.2008.06.056","article-title":"Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia","volume":"102","author":"Civeira","year":"2008","journal-title":"Am J Cardiol"},{"key":"R50-20230917","first-page":"574","article-title":"Improving the yield of genetic testing in familial hypercholesterolaemia","volume":"38","author":"Ajufo","year":"2016","journal-title":"Eur Heart J"},{"key":"R51-20230917","first-page":"565","article-title":"Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemia","volume":"38","author":"Besseling","year":"2016","journal-title":"Eur Heart J"},{"key":"R52-20230917","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/heartjnl-2012-302917","article-title":"Effectiveness of alternative strategies to define index case phenotypes to aid genetic diagnosis of familial hypercholesterolaemia","volume":"99","author":"Clarke","year":"2013","journal-title":"Heart"},{"key":"R53-20230917","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5551\/jat.34108","article-title":"International developments in the care of familial hypercholesterolemia: where now and where to next?","volume":"23","author":"Pang","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"R54-20230917","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/2047487316680696","article-title":"Registries, codifications and cardiovascular outcomes in familial hypercholesterolaemia","volume":"24","author":"Ellis","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"R55-20230917","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet"},{"key":"R56-20230917","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ahj.2013.12.008","article-title":"Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry","volume":"167","author":"O\u2019Brien","year":"2014","journal-title":"Am Heart J"},{"key":"R57-20230917","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/bmj.321.7254.148","article-title":"Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study","volume":"321","author":"Neil","year":"2000","journal-title":"BMJ"},{"key":"R58-20230917","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-511X-10-94","article-title":"Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)","volume":"10","author":"Mata","year":"2011","journal-title":"Lipids Health Dis"},{"key":"R59-20230917","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/archdischild-2015-308570","article-title":"The UK Paediatric Familial Hypercholesterolaemia Register: preliminary data","volume":"102","author":"Ramaswami","year":"2016","journal-title":"Arch Dis Child"},{"key":"R60-20230917","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.001","article-title":"Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration","volume":"22","author":"Vallejo-Vaz","year":"2016","journal-title":"Atheroscler Suppl"},{"key":"R61-20230917","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/1744-1609.12023","article-title":"Role of international registries in enhancing the care of familial hypercholesterolaemia","volume":"11","author":"Hammond","year":"2013","journal-title":"Int J Evid Based Healthc"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00041433-201708000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T08:10:49Z","timestamp":1694938249000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041433-201708000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000423","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}